Bipolar disorder treatment often includes some combination of medications like mood stabilizers and antidepressants alongside therapy.

The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I ...

FDA approves UZEDY® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive ...

Teva Pharmaceutical Industries Limited TEVA recently announced that the FDA has approved expanded use of its branded product, ...

While borderline personality disorder and bipolar disorder share common symptoms like reckless behavior, there are a few key ...

Bipolar disorder exists on a spectrum rather than as a single, uniform condition. This fundamental characteristic explains why two people with the same diagnosis can experience dramatically different ...

Teva Pharmaceuticals' Uzedy therapy to treat bipolar I disorder received approval from the Food and Drug Administration. The biopharmaceutical company said Friday the therapy was approved as a ...

This is a developing news story. Please check back soon for updates. The FDA approved extended-release Uzedy for the ...

Dr. Robert Findling answers the question: 'Group Therapy For Bipolar Disorder?' — -- Question: How effective is group therapy for the treatment of bipolar disorder in children/adolescents? Answer ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can impact daily functioning and behavior. Although bipolar disorder is a chronic ...

It used to be called manic depression in an effort to capture the swing of emotions from intense manic highs to the lowest of lows. Today it’s called bipolar disorder, another way to describe a mental ...

Paris: The FDA has approved UZEDY, the first subcutaneous long-acting risperidone formulation utilizing SteadyTeq™ technology ...